The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
ESOT is pleased to announce the appointment of two new members to the board of its Basic Science Committee (BSC): Oscar Gonzalez Fernandez – Consultant Cardiologist in Heart Transplant and Advanced Heart Failure at Freeman Hospital, and Associated Clinical Lecturer at the Translational and Clinical Research Institute, Newcastle University (Newcastle, United Kingdom). Serena MacMillan –
BSC – the Basic Science Committee- would like to announce a call for nominations for two Board members. The new BSC Board Members will hold office for four years (2025-2029), starting in September 2025. All ESOT/BSC affiliates are eligible to submit their applications for the positions. You may nominate yourself or a colleague. In
The ESOT Basic Science Webinar series has resumed after a brief break, kicking off with “Xenotransplantation: The Future is Now – Past, Present, and Future Challenges.” The session covered advancements and the translation of cutting-edge transplant science, focusing on recent breakthroughs and ongoing challenges in xenotransplantation. The distinguished international panel featured experts in the field:
Improving transplant patient outcomes is at the forefront of our mission and, we are eager to collaborate with research teams who share the common goal of improving the lives of those hindered by inequitable access to life-changing treatments and procedures. Here’s why our involvement can be a game-changer for your project: Unmatched Expertise: With a
We are pleased to announce that our latest workshop, titled “Managing CMV in Solid Organ Transplant Recipients” is now available on ESOT Transplant Live [when in Transplant Live please go to Courses]. This educational programme aims to enhance the management of Cytomegalovirus (CMV) infections among transplant recipients, which can pose a significant challenge post-surgery. The
Aimed at young professional working in solid organ transplant, this Masterclass will provide crucial insight into the cutting-edge technologies that are about to revolutionise the transplantation field, including cell-free DNA, new plasma, urinary and immune function biomarkers, gene-expression profiling, as well as recent advances on HLA and non-HLA antibodies.
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
BSC – the Basic Science Committee- would like to announce a call for nominations for four Board members. The new BSC Board Members will hold office for four years (2023-2027), starting at the ESOT Congress, September 2023. All ESOT/BSC affiliates are eligible to submit their applications for the positions. You may nominate yourself or a
“What has been achieved in tissue engineering and regenerative medicine?” Tissue engineering and organ regeneration expert, Ekaterine Berishvili, discusses the progress, opportunities and challenges of regeneration and repair in organ transplantation.
The Basic Science Committee would like to announce a call for nominations for one new Board member. ESOT/Basic Science Committee affiliates are eligible to submit their application for the positions. Applications from PhDs with some years of postdoc experience and researchers with a strong basic science background will be given preferential consideration. The Board reserves
